Skip to content
healthcare.dev

Doxylamine succinate and pyridoxine hydrochloride

NDC 0591-2132, Doxylamine succinate and pyridoxine hydrochloride, tablet, delayed release, from Actavis Pharma, Inc..

Product NDC
0591-2132
Status
Listed
Labeler
Actavis Pharma, Inc.
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205811
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2132 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXYLAMINE SUCCINATE10 mg/1
  • PYRIDOXINE HYDROCHLORIDE10 mg/1

Pharmacologic classes

Analogs/Derivatives [Chemical/Ingredient]; Antihistamine [EPC]; Histamine Receptor Antagonists [MoA]; Vitamin B 6 [Chemical/Ingredient]; Vitamin B6 Analog [EPC]

Package NDCNDC-11Package
0591-2132-0100591213201100 TABLET, DELAYED RELEASE in 1 BOTTLE (0591-2132-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3670d66e-c1e4-42ce-8760-c3d5accad925
  • NADAC price for package 00591213201

    GET /v1/drugs/nadac/00591213201

Use it

Look up 0591-2132 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2132 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0591-2132. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.